Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer
- Conditions
- Stage IIIB Prostate CancerStage IIIA Prostate CancerStage IV Prostate CancerStage III Prostate CancerStage IIIC Prostate CancerStage IVA Prostate CancerStage IVB Prostate Cancer
- Interventions
- Procedure: Radical ProstatectomyRadiation: Stereotactic Body Radiation Therapy (SBRT)Biological: Anti-PD-1 Monoclonal Antibody REGN2810
Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma
- Conditions
- Glioblastoma
- Interventions
- Radiation: Radiation TherapyDevice: NovoTTF-200A DeviceProcedure: Tumor Treating Fields Therapy
- First Posted Date
- 2018-03-26
- Last Posted Date
- 2025-05-15
- Target Recruit Count
- 30
- Registration Number
- NCT03477110
- Locations
- πΊπΈ
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver
- Conditions
- Metastatic Malignant Neoplasm in the LiverMetastatic Uveal MelanomaStage IV Uveal Melanoma AJCC v7
- Interventions
- First Posted Date
- 2018-03-21
- Last Posted Date
- 2025-04-24
- Target Recruit Count
- 14
- Registration Number
- NCT03472586
- Locations
- πΊπΈ
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Palbociclib and Dexamethasone in Treating Participants With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
- Conditions
- Refractory B Acute Lymphoblastic LeukemiaRecurrent B Acute Lymphoblastic Leukemia
- Interventions
- First Posted Date
- 2018-03-21
- Last Posted Date
- 2025-05-15
- Target Recruit Count
- 7
- Registration Number
- NCT03472573
- Locations
- πΊπΈ
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery
- First Posted Date
- 2018-01-19
- Last Posted Date
- 2025-04-24
- Target Recruit Count
- 26
- Registration Number
- NCT03405155
- Locations
- πΊπΈ
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
πΊπΈColumbia University, New York, New York, United States
πΊπΈUniveristy of Pennsylvania, Philadelphia, Pennsylvania, United States
CPI-613 in Combination With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer
- Conditions
- Pancreatic Ductal Adenocarcinoma
- Interventions
- Drug: mFOLFIRNOX
Nivolumab, Cisplatin, and Pemetrexed Disodium or Gemcitabine Hydrochloride in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery
- Conditions
- Non-Squamous Non-Small Cell Lung CarcinomaStage I Non-Small Cell Lung CancerStage IIB Non-Small Cell Lung CarcinomaStage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung CarcinomaStage IIIA Non-Small Cell Lung CancerStage II Non-Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2017-12-08
- Last Posted Date
- 2023-04-03
- Target Recruit Count
- 14
- Registration Number
- NCT03366766
- Locations
- πΊπΈ
Abington Hospital - Jefferson Health, Abington, Pennsylvania, United States
πΊπΈSidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery
- Conditions
- Stage III Oral Cavity Squamous Cell CarcinomaStage IV Laryngeal Squamous Cell CarcinomaStage IV Oropharyngeal Squamous Cell CarcinomaStage IVA Hypopharyngeal Squamous Cell CarcinomaStage IVA Oral Cavity Squamous Cell CarcinomaStage IVB Laryngeal Squamous Cell CarcinomaStage IV Oral Cavity Squamous Cell CarcinomaName Human Papillomavirus Positive Oropharyngeal Squamous Cell CarcinomaStage IVA Oropharyngeal Squamous Cell CarcinomaStage IVB Hypopharyngeal Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2017-11-17
- Last Posted Date
- 2025-04-24
- Target Recruit Count
- 34
- Registration Number
- NCT03342911
- Locations
- πΊπΈ
Abington- Jefferson Health, Abington, Pennsylvania, United States
πΊπΈSidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
πΊπΈFox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Automated Device for Asthma Monitoring and Management in Monitoring Adults With Lung Cancer Undergoing Radiation Therapy
- Conditions
- Lung Carcinoma
- Interventions
- Device: Monitoring Device
- First Posted Date
- 2017-11-13
- Last Posted Date
- 2025-05-15
- Target Recruit Count
- 24
- Registration Number
- NCT03340714
- Locations
- πΊπΈ
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma
- Conditions
- Non-Hodgkin's LymphomaPlasma Cell Myeloma
- Interventions
- Procedure: Hematopoietic Cell TransplantationOther: Laboratory Biomarker Analysis
- First Posted Date
- 2017-10-23
- Last Posted Date
- 2022-11-17
- Target Recruit Count
- 76
- Registration Number
- NCT03317899
- Locations
- πΊπΈ
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States